"10.1371_journal.pone.0024303","plos one","2011-09-15T00:00:00Z","Lavinia Paternoster; David M Evans; Ellen Aagaard Nohr; Claus Holst; Valerie Gaborieau; Paul Brennan; Anette Prior Gjesing; Niels Grarup; Daniel R Witte; Torben Jørgensen; Allan Linneberg; Torsten Lauritzen; Anelli Sandbaek; Torben Hansen; Oluf Pedersen; Katherine S Elliott; John P Kemp; Beate St. Pourcain; George McMahon; Diana Zelenika; Jörg Hager; Mark Lathrop; Nicholas J Timpson; George Davey Smith; Thorkild I A Sørensen","MRC CAiTE centre, University of Bristol, Bristol, United Kingdom; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom; Institute of Public Health, Aarhus University, Aarhus, Denmark; Institute of Preventive Medicine, Copenhagen University Hospitals, Copenhagen, Denmark; International Agency for Research on Cancer (IARC), Lyon, France; The Novo Nordisk Center for Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Steno Diabetes Center, Copenhagen, Denmark; Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark; Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark; Department of General Practice, University of Aarhus, Aarhus, Denmark; Institute of Biomedical Science, Faculty of Health Science, University of Copenhagen, Copenhagen, Demark; Faculty of Health Science, University of Aarhus, Aarhus, Denmark; Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; Centre National de Génotypage, Evry, France; Foundation Jean Dausset, CEPH, Paris, France","Conceived and designed the experiments: LP DME EAN TJ AL TL AS TH OP ML GDS NJT TIAS. Analyzed the data: LP DME EAN CH VG APG NG KSE. Contributed reagents/materials/analysis tools: PB DRW TJ TL AS TH OP JPK BSP GM JH DZ ML TIAS. Wrote the paper: LP DME EAN CH VG PB APG NG AL TJ OP KSE JPK BSP JH NJT GDS TIAS.","The authors have read the journals policy and have the following conflicts: the ADDITION study received public funds as well as unrestricted grants from Novo Nordisk, Novo Nordisk Scandinavia, Astra Denmark, Pfizer Denmark, GlaxoSmithKline Pharma Denmark, Servier Denmark and HemoCue Denmark. Anette Prior Gjesing, Niels Grarup, Torben Hansen, and Oluf Pedersen were employees of the Hagedorn Research Institute. There are no patents, products in development, or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","09","Lavinia Paternoster","LP",25,TRUE,13,NA,8,18,TRUE,TRUE,FALSE,0,NA,FALSE
